2024-01-012024-12-312024-12-31false07780931MEDICO-DENTAL HOLDINGS LIMITED2025-09-3064209falseiso4217:GBPxbrli:pure077809312023-12-31077809312024-12-31077809312024-01-012024-12-31077809312022-12-31077809312023-12-31077809312023-01-012023-12-3107780931bus:SmallEntities2024-01-012024-12-3107780931bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3107780931bus:AbridgedAccounts2024-01-012024-12-3107780931bus:PrivateLimitedCompanyLtd2024-01-012024-12-3107780931core:WithinOneYear2024-12-3107780931core:AfterOneYear2024-12-3107780931core:WithinOneYear2023-12-3107780931core:AfterOneYear2023-12-3107780931core:ShareCapital2024-12-3107780931core:SharePremium2024-12-3107780931core:RevaluationReserve2024-12-3107780931core:OtherReservesSubtotal2024-12-3107780931core:RetainedEarningsAccumulatedLosses2024-12-3107780931core:ShareCapital2023-12-3107780931core:SharePremium2023-12-3107780931core:RevaluationReserve2023-12-3107780931core:OtherReservesSubtotal2023-12-3107780931core:RetainedEarningsAccumulatedLosses2023-12-3107780931core:LandBuildings2024-12-3107780931core:PlantMachinery2024-12-3107780931core:Vehicles2024-12-3107780931core:FurnitureFittings2024-12-3107780931core:OfficeEquipment2024-12-3107780931core:NetGoodwill2024-12-3107780931core:IntangibleAssetsOtherThanGoodwill2024-12-3107780931core:ListedExchangeTraded2024-12-3107780931core:UnlistedNon-exchangeTraded2024-12-3107780931core:LandBuildings2023-12-3107780931core:PlantMachinery2023-12-3107780931core:Vehicles2023-12-3107780931core:FurnitureFittings2023-12-3107780931core:OfficeEquipment2023-12-3107780931core:NetGoodwill2023-12-3107780931core:IntangibleAssetsOtherThanGoodwill2023-12-3107780931core:ListedExchangeTraded2023-12-3107780931core:UnlistedNon-exchangeTraded2023-12-3107780931core:LandBuildings2024-01-012024-12-3107780931core:PlantMachinery2024-01-012024-12-3107780931core:Vehicles2024-01-012024-12-3107780931core:FurnitureFittings2024-01-012024-12-3107780931core:OfficeEquipment2024-01-012024-12-3107780931core:NetGoodwill2024-01-012024-12-3107780931core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107780931core:ListedExchangeTraded2024-01-012024-12-3107780931core:UnlistedNon-exchangeTraded2024-01-012024-12-3107780931core:MoreThanFiveYears2024-01-012024-12-3107780931core:Non-currentFinancialInstruments2024-12-3107780931core:Non-currentFinancialInstruments2023-12-3107780931dpl:CostSales2024-01-012024-12-3107780931dpl:DistributionCosts2024-01-012024-12-3107780931core:LandBuildings2024-01-012024-12-3107780931core:PlantMachinery2024-01-012024-12-3107780931core:Vehicles2024-01-012024-12-3107780931core:FurnitureFittings2024-01-012024-12-3107780931core:OfficeEquipment2024-01-012024-12-3107780931dpl:AdministrativeExpenses2024-01-012024-12-3107780931core:NetGoodwill2024-01-012024-12-3107780931core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107780931dpl:GroupUndertakings2024-01-012024-12-3107780931dpl:ParticipatingInterests2024-01-012024-12-3107780931dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3107780931core:ListedExchangeTraded2024-01-012024-12-3107780931dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3107780931core:UnlistedNon-exchangeTraded2024-01-012024-12-3107780931dpl:CostSales2023-01-012023-12-3107780931dpl:DistributionCosts2023-01-012023-12-3107780931core:LandBuildings2023-01-012023-12-3107780931core:PlantMachinery2023-01-012023-12-3107780931core:Vehicles2023-01-012023-12-3107780931core:FurnitureFittings2023-01-012023-12-3107780931core:OfficeEquipment2023-01-012023-12-3107780931dpl:AdministrativeExpenses2023-01-012023-12-3107780931core:NetGoodwill2023-01-012023-12-3107780931core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3107780931dpl:GroupUndertakings2023-01-012023-12-3107780931dpl:ParticipatingInterests2023-01-012023-12-3107780931dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3107780931core:ListedExchangeTraded2023-01-012023-12-3107780931dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3107780931core:UnlistedNon-exchangeTraded2023-01-012023-12-3107780931core:NetGoodwill2024-12-3107780931core:IntangibleAssetsOtherThanGoodwill2024-12-3107780931core:LandBuildings2024-12-3107780931core:PlantMachinery2024-12-3107780931core:Vehicles2024-12-3107780931core:FurnitureFittings2024-12-3107780931core:OfficeEquipment2024-12-3107780931core:AfterOneYear2024-12-3107780931core:WithinOneYear2024-12-3107780931core:ListedExchangeTraded2024-12-3107780931core:UnlistedNon-exchangeTraded2024-12-3107780931core:ShareCapital2024-12-3107780931core:SharePremium2024-12-3107780931core:RevaluationReserve2024-12-3107780931core:OtherReservesSubtotal2024-12-3107780931core:RetainedEarningsAccumulatedLosses2024-12-3107780931core:NetGoodwill2023-12-3107780931core:IntangibleAssetsOtherThanGoodwill2023-12-3107780931core:LandBuildings2023-12-3107780931core:PlantMachinery2023-12-3107780931core:Vehicles2023-12-3107780931core:FurnitureFittings2023-12-3107780931core:OfficeEquipment2023-12-3107780931core:AfterOneYear2023-12-3107780931core:WithinOneYear2023-12-3107780931core:ListedExchangeTraded2023-12-3107780931core:UnlistedNon-exchangeTraded2023-12-3107780931core:ShareCapital2023-12-3107780931core:SharePremium2023-12-3107780931core:RevaluationReserve2023-12-3107780931core:OtherReservesSubtotal2023-12-3107780931core:RetainedEarningsAccumulatedLosses2023-12-3107780931core:NetGoodwill2022-12-3107780931core:IntangibleAssetsOtherThanGoodwill2022-12-3107780931core:LandBuildings2022-12-3107780931core:PlantMachinery2022-12-3107780931core:Vehicles2022-12-3107780931core:FurnitureFittings2022-12-3107780931core:OfficeEquipment2022-12-3107780931core:AfterOneYear2022-12-3107780931core:WithinOneYear2022-12-3107780931core:ListedExchangeTraded2022-12-3107780931core:UnlistedNon-exchangeTraded2022-12-3107780931core:ShareCapital2022-12-3107780931core:SharePremium2022-12-3107780931core:RevaluationReserve2022-12-3107780931core:OtherReservesSubtotal2022-12-3107780931core:RetainedEarningsAccumulatedLosses2022-12-3107780931core:AfterOneYear2024-01-012024-12-3107780931core:WithinOneYear2024-01-012024-12-3107780931core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3107780931core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3107780931core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3107780931core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3107780931core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3107780931core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3107780931core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3107780931core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3107780931core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3107780931core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3107780931core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3107780931core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3107780931core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3107780931core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3107780931core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3107780931core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3107780931core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3107780931core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3107780931core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3107780931core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3107780931core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3107780931core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3107780931core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3107780931core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3107780931core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3107780931core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3107780931core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3107780931bus:Director12024-01-012024-12-31

MEDICO-DENTAL HOLDINGS LIMITED

Registered Number
07780931
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

MEDICO-DENTAL HOLDINGS LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Director

FLANAGAN, Lisa Margaret

Registered Address

Montvale House Wells Road
Hallatrow
Bristol
BS39 6EJ

Registered Number

07780931 (England and Wales)
MEDICO-DENTAL HOLDINGS LIMITED
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Investments317,000,19517,000,195
17,000,19517,000,195
Current assets
Debtors4,382,2534,701,911
Cash at bank and on hand25,49348,975
4,407,7464,750,886
Creditors amounts falling due within one year4(3,963,882)(3,987,382)
Net current assets (liabilities)443,864763,504
Total assets less current liabilities17,444,05917,763,699
Creditors amounts falling due after one year(17,887,510)(18,198,101)
Net assets(443,451)(434,402)
Capital and reserves
Called up share capital1,8381,838
Share premium1,561,2531,561,253
Profit and loss account(2,006,542)(1,997,493)
Shareholders' funds(443,451)(434,402)
The financial statements were approved and authorised for issue by the Director on 30 September 2025, and are signed on its behalf by:
FLANAGAN, Lisa Margaret
Director
Registered Company No. 07780931
MEDICO-DENTAL HOLDINGS LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20242023
Average number of employees during the year00
3.Fixed asset investments

Total

£
Cost or valuation
At 01 January 2417,000,195
At 31 December 2417,000,195
Net book value
At 31 December 2417,000,195
At 31 December 2317,000,195
4.Creditors: amounts due within one year

2024

2023

££
Other creditors2,383,1032,406,603
Accrued liabilities and deferred income1,580,7791,580,779
Total3,963,8823,987,382
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.